JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

This study details purification of KIF1A(1-393LZ), a member of kinesin-3 family, using Sf9-baculovirus expression system. In vitro single-molecule and multi-motor gliding analysis of these purified motors exhibited robust motility properties comparable to motors from mammalian cell lysate. Thus, Sf9-baculovirus system is amenable to express and purify motor protein of interest.

Streszczenie

A complex cellular environment poses challenges for single-molecule motility analysis. However, advancement in imaging techniques have improved single-molecule studies and has gained immense popularity in detecting and understanding the dynamic behavior of fluorescent-tagged molecules. Here, we describe a detailed method for in vitro single-molecule studies of kinesin-3 family motors using Total Internal Reflection Fluorescence (TIRF) microscopy. Kinesin-3 is a large family that plays critical roles in cellular and physiological functions ranging from intracellular cargo transport to cell division to development. We have shown previously that constitutively active dimeric kinesin-3 motors exhibit fast and superprocessive motility with high microtubule affinity at the single-molecule level using cell lysates prepared by expressing motor in mammalian cells. Our lab studies kinesin-3 motors and their regulatory mechanisms using cellular, biochemical and biophysical approaches, and such studies demand purified proteins at a large scale. Expression and purification of these motors using mammalian cells would be expensive and time-consuming, whereas expression in a prokaryotic expression system resulted in significantly aggregated and inactive protein. To overcome the limitations posed by bacterial purification systems and mammalian cell lysate, we have established a robust Sf9-baculovirus expression system to express and purify these motors. The kinesin-3 motors are C-terminally tagged with 3-tandem fluorescent proteins (3xmCitirine or 3xmCit) that provide enhanced signals and decreased photobleaching. In vitro single-molecule and multi-motor gliding analysis of Sf9 purified proteins demonstrate that kinesin-3 motors are fast and superprocessive akin to our previous studies using mammalian cell lysates. Other applications using these assays include detailed knowledge of oligomer conditions of motors, specific binding partners paralleling biochemical studies, and their kinetic state.

Wprowadzenie

An immensely crowded cell environment poses many challenges in sorting destined proteins and molecules. This intense workload of organization and spatiotemporal distribution of molecules within the cytoplasm is facilitated by molecular motors and cytoskeletal tracks. Molecular motors are the enzymes that hydrolyze the energy currencies such as ATP and utilize that energy during motion and force generation1. Based on the amino acid sequence similarity, kinesins are grouped into 14 families and despite this similarity, each motor contributes uniquely to the functioning of a cell. Kinesin-3 family motors constitute one of the largest, comprising five subfamilies (KIF1, KIF13, KIF14, KIF16, and KIF28)2, associated with diverse cellular and physiological functions, including vesicle transport, signaling, mitosis, nuclear migration, and development 3,4,5. Impairment in kinesin-3 transport function implicates in many neurodegenerative disorders, developmental defects, and cancer diseases6,7,8,9.

Recent work has demonstrated that kinesin-3 motors are monomers but undergo cargo-induced dimerization and result in fast and superprocessive motility compared to conventional kinesin10,11,12,13. Their biochemical and biophysical characterization needs a large quantity of purified, active proteins. However, their production in the prokaryotic expression system resulted in inactive or aggregated motors, presumably due to incompatible protein synthesis, folding and modification machinery14,15,16,17,18. To circumvent such limitations and increase the yield, here we have established a robust Sf9-baculovirus expression system to express and purify these motors.

The baculovirus expression system uses Sf9 insect cell lines as a host system for high-throughput eukaryotic recombinant protein expression19,20. Baculovirus possesses a strong polyhedrin promoter that assists in heterologous gene expression and the production of soluble recombinant proteins17. Due to its cost-effectiveness, safe to handle and high amount of active protein expression, it has become a powerful tool21. To express a protein of interest, a key step is to generate a recombinant bacmid. Since the commercially available bacmid generating kits are expensive and we will be working with more samples, we developed an in-house protocol for both large and small inserts of kinesin-3 motors into bacmids. Sf9-purified kinesin-3 motors were used to characterize in vitro single-molecule and multi-motor microtubule gliding properties using total internal reflection fluorescence (TIRF) microscopy. Motors are C-terminally tagged with 3-tandem fluorescent molecules (3xmCit) to provide enhanced signal and decreased photobleaching. Due to its increased signal-to-noise ratio, less phototoxicity, and selective imaging of a very small area close to the coverslip, TIRF imaging has been widely used to visualize protein dynamics at the single-molecule level in vivo and in vitro.

This study discusses the purification of kinesin-3 motors by employing Sf9-baculovirus expression system and in vitro single-molecule imaging and multi-motor gliding analysis of motors using TIRF microscopy. Altogether, this study shows that the motility properties of Sf9 purified motors are identical to that of motors prepared from mammalian cell lysates. Hence, we believe that the Sf9-baculovirus system can be adapted to express and purify any motor protein of interest.

Protokół

1. Sf9 culture, transfection, and virus generation

NOTE: Maintain Sf9 cells in 30 mL of Sf-900/SFM medium in 100 mL sterile, disposable conical flask without any antibiotic/antimycotic at 28 °C. Keep the suspension culture in an orbital shaker at 90 rpm. Supply of CO2 and humidity maintenance is not required. Cells are usually subcultured every fourth day by inoculating 0.5 x 106 cells/mL to reach 2.0 x 106 cells/mL density on the fourth day.

  1. P0 virus stock generation
    1. For transfection, seed cells into a 35 mm dish with 4.5 x 105 cells/mL confluency and maintain at 28 °C without shaking.
    2. After 24 h, once cells are attached and look healthy, proceed for transfection as described below.
      1. Tube A: Mix 1 µg of bacmid DNA encoding for constitutively active KIF1A(1-393LZ)-3xmCit-FLAG specific kinesin-3 motor with 100 µL of unsupplemented Grace's media.
      2. Tube B: Mix 6 µL of transfection reagent with 100 µL of unsupplemented Grace's media.
      3. Carefully transfer the content of Tube A into Tube B and mix thoroughly by pipetting up and down (approximately 20 times).
      4. Incubate the mixture for ~45 min at room temperature.
    3. After completing the incubation, add 0.8 mL of unsupplemented Grace's media to the above mixture and mix slowly by pipetting.
    4. Gently aspirate the Sf-900/SFM media from cells (to remove any traces of serum that may affect transfection efficiency).
    5. Add the transfection mixture from step 1.1.3 dropwise on the top of the cells and incubate the plate for 6 h at 28 °C.
    6. After the incubation, carefully remove the transfection mixture, add 2 mL of Sf-900/SFM media and incubate further for 48 h at 28 °C.
    7. Check for the motor protein expression under an inverted fluorescence microscope. The motor protein is tagged with a fluorescent protein, mCitrine, a variant of yellow fluorescent protein.
      NOTE: Transfected cells were visualized under an inverted microscope equipped with differential interference contrast (DIC) and epifluorescence illumination with a 20x objective (200 times magnification), mercury lamp and an EM-CCD camera. Check the efficiency of virus generation and infection by monitoring the expression of mCitrine-tagged motors in cells through mCitrine excitation and emission filter cube. In addition, check for morphological changes of infected cells, such as enlarged cells/nuclei (Figure 1A-C).
    8. Again, check the cells 72 h post-infection. Usually, cells start detaching from the surface (Figure 2).
    9. If >5% of cells detached from the surface, harvest the media with infected cells in 1.5 mL sterile microcentrifuge tubes and spin for 5 min at 500 x g.
    10. Collect the supernatant and snap freeze aliquots of 1 mL in liquid nitrogen and store as P0 stock at -80 °C or use it to generate P1 virus stock.
  2. P1 virus stock generation
    1. To further amplify the P0 baculovirus stock and confirm protein expression, grow Sf9 cells in liquid suspension culture.
    2. In a sterile 100 mL conical flask, add 10 mL of Sf-900/SFM media with a cell density of 2 x 106 cells/mL and 1 mL of P0 virus stock. Incubate at 28 °C with constant shaking at 90 rpm.
    3. After 72 h of infection, check for the protein expression as described earlier (step 1.1.7). If the protein expression is good (>90% of cells show a bright mCitrine fluorescence signal) and shows significant cell death (approximately 10%-15%), spin down the cells in a 15 mL sterile conical tube at 500 x g for 5 min.
    4. Collect the supernatant, snap freeze aliquots of 1 mL (P1 stock) in liquid nitrogen and store at -80°C or proceed for large-scale infection and protein purification.
  3. Large-scale infection
    1. For large-scale protein expression, infect 30 mL of the suspension culture at 2 x 106 cells/mL density with 1 mL of P1 virus stock and incubate at 28 °C with constant shaking at 90 rpm.
    2. After ~72 h post-infection, check for the protein expression (in general, maximum protein expression is achieved between 65-75h post-infection).
    3. If >90% of cells show a bright fluorescent signal with minimal cell death (<5%), collect the cells in a sterile 50 mL conical tube and spin down at 500 x g at 4 °C for 15 min.
      ​NOTE: There should be minimal cell death (<5%), because dead cells release the cellular contents into the media, which leads to loss of expressed protein.
    4. Discard the supernatant, collect the cell pellet, and proceed with protein purification.

2. Sf9 purification of kinesin-3 motors

  1. To the above cell pellet, add 3 mL of ice-cold lysis buffer (Supplemental Table 1) freshly supplemented with 5 mM DTT, 5 µg/mL of aprotinin, 5 µg/mL of leupeptin, and 5 µg/mL of PMSF and lyse the cells by pipetting 20-25 times without generating any air bubbles. For all the buffer compositions and reagents, please refer to Supplemental Table 1.
  2. Spin the cell lysate at 150,000 x g for 30 min at 4 °C.
  3. Collect the supernatant into a fresh, sterile tube and mix with ~40 µL of 50% anti-FLAG M2 affinity resin. Incubate the mixture for 3 h at 4 °C with end-to-end tumbling.
  4. After incubation, pellet the FLAG resin by spinning at 500 x g for 1 min at 4 °C. Gently aspirate the supernatant without disturbing the pellet with a 26 G needle and discard.
  5. Wash the FLAG resin pellet three times with ice-cold wash buffer (Supplemental Table 1) freshly supplemented with 2 mM DTT, 5 µg/mL of aprotinin, 5 µg/mL of leupeptin, and 5 µg/mL of PMSF. Pellet the beads by spinning at 500 x g for 1 min at 4 °C in each wash.
  6. After the third wash, carefully drain the wash buffer as much as possible without disturbing the pellet. For protein elution, add ~70 µL of wash buffer containing 100 µg/mL FLAG peptide to the resin pellet and incubate overnight at 4 °C with end-to-end tumbling.
  7. On the subsequent day, spin down the resin at 500 x g for 1 min at 4 °C. Collect the supernatant containing purified protein into a fresh tube and supplement with 10% glycerol. Snap freeze aliquots of 5 µL in liquid nitrogen and store at -80 °C until further use.
  8. Run the SDS-PAGE gel to determine the protein concentration and yield. Along with purified protein of interest, a standard protein control, BSA of known concentrations ranging from 0.2 µg, 0.4 µg, 0.6 µg, 0.8 µg, and 1 µg are loaded to generate a standard curve. Stain the gel with Coomassie Brilliant blue (Figure 3).
  9. Analyze the gel using a built-in gel quantification tool in ImageJ software. First, measure the band intensity of known concentrations of BSA and generate the standard curve. Then, measure the intensity of the purified protein band and determine the protein concentration. To do so open the Image J software, click on the Analyze option in the menu bar and select Gels in the drop-down menu.

3. In vitro single-molecule motility assay using Sf9-purified kinesin-3 motors

NOTE: The Sf9-purified kinesin-3 motors can be used to study biochemical and biophysical properties such as ATP turnover rate, microtubule affinity, velocity, run length, step size, and force generation. Here, a detailed protocol for in vitro single-molecule motility analysis of KIF1A(1-393LZ) using Total Internal Reflection Fluorescence (TIRF) microscopy is described. For all the buffers composition and reagents, please refer to Supplemental Table 1.

  1. Microtubule polymerization
    1. In a pre-chilled 0.5 mL microcentrifuge tube, prepare a polymerization mix by pipetting in the following order: 12.0 µL of BRB80 buffer, pH 6.9; 0.45 µL of 100 mM MgCl2, 1 µL of 25 mM GTP.
    2. Take out a 10 µL aliquot of 10 mg/mL tubulin stored in liquid nitrogen, thaw immediately, and add into the above polymerization mixture. Mix gently by pipetting 2-3 times without creating any air bubbles.
      NOTE: Perform the above steps quickly and strictly on ice.
    3. Let the above mixture sit on ice for 5 min.
      NOTE: This is a critical step to prevent denaturing of tubulin or to avoid the formation of short microtubule seeds.
    4. Transfer the tube into a pre-warmed 37 °C heat block/water bath and incubate for 30 min for polymerization of microtubules.
    5. While microtubules are polymerizing, thaw an aliquot of P12 buffer and bring it to room temperature.
    6. Before completing 30 min of incubation, start preparing MT stabilization buffer by pipetting 100 µL of P12 buffer into a fresh microcentrifuge tube. To this, add 1 µL of 1 mM taxol and immediately vortex the mixture.
      NOTE: Start preparing the MT stabilization buffer approximately 5 min before completing the incubation in step 3.1.4. Taxol stabilizes the polymerized microtubules by binding to β-tubulin.
    7. Warm the microtubule stabilization buffer for 2-3 min at 37 °C and gently add it to the polymerized microtubules without disturbing the polymerization mixture at the bottom.
      ​NOTE: Warming the stabilization buffer will bring it to the same temperature as the polymerization mixture.
    8. Do not tap or pipette the mixture and incubate further at 37 °C for 5 min.
    9. Gently tap the mixture and mix it with a beveled cut tip (200 µL capacity) slowly using the pipette.
      NOTE: From this point onward, always handle microtubules with a beveled cut tip to avoid microtubule shearing.
    10. Take 10-15 µL of polymerized microtubules in a flow cell to check proper microtubule polymerization.
      NOTE: One can visualize the unlabeled microtubules using a DIC microscopy setup.
    11. If microtubules are concentrated, dilute them in P12 buffer supplemented with 10 µM taxol.
  2. Preparation of motility flow cell chamber
    1. Prepare a motility chamber using a glass slide, double-sided tape and glass coverslip (22 mm x 30 mm).
    2. Take a glass slide, place a drop (~70 µL) of deionized distilled water in the middle and wipe it with a lint-free tissue paper.
    3. Cut two strips of double-sided tape (~35 x 3 mm) and firmly stick them to the glass slide parallelly, leaving an ~4-5 mm gap between two strips to create a narrow passage.
    4. Next, take a coverslip and add a drop (~20 µL) of deionized distilled water in the middle. Place a strip of lint-free lens cleaning tissue paper on the water drop until it absorbs the water. Then, slide it slowly toward one end of the coverslip.
      NOTE: The coverslip should be completely dry. No water should be visible on the coverslip.
    5. Place the coverslip on the double-sided strips stuck on the slide and press the coverslip evenly along the strips to stick firmly.
      NOTE: Please make sure that the cleaned side of the coverslip faces the glass slide.
    6. Ensure that together this creates a narrow chamber of 10-15 µL capacity for performing motility assay (Figure 4A).
  3. In vitro single-molecule motility assay
    NOTE: To study the microtubule-based single-molecule motility properties of motors, microtubules need to be adsorbed onto the coverslip surface in the motility chamber.
    1. Dilute the polymerized taxol-stabilized microtubules in P12 buffer supplemented with 10 µM taxol at 1:5 ratios and mix by pipetting slowly with a beveled tip.
    2. Keep the flow chamber in a slant position (~15-20°). Flow 30 µL of diluted microtubule solution through the flow chamber from the upper end while keeping a lint-free tissue paper at the lower end to absorb the liquid. This creates a shear force to align the microtubule in the flow direction and helps to adsorb the microtubules straight and align parallel.
    3. Leave a small drop of liquid on both ends of the chamber and keep the flow cell in an inverted position (coverslip facing the bottom) in a closed, moist chamber to prevent drying of the motility chamber.
    4. Let it sit for ~30 min so that microtubules adsorb to the surface of the coverslip inside the motility chamber.
    5. In the meantime, prepare blocking buffer by mixing 500 µL P12-BSA buffer with 5 µL of 1 mM taxol.
    6. Flow 40-50 µL of blocking buffer and incubate the slide in an inverted position for 10 min in a moist chamber.
    7. Prepare the motility mixture by pipetting the following components into a 500 µL capacity sterile microcentrifuge tube in the following order: 25 µL of P12 buffer with taxol, 0.5 µL of 100 mM MgCl2, 0.5 µL of 100 mM DTT, 0.5 µL of 20 mg/mL Glucose oxidase, 0.5 µL of 8 mg/mL Catalase, 0.5 µL of 2.25 M Glucose, and 1.0 µL of 100 mM ATP.
      NOTE: Fluorescence imaging has been widely used for biological applications22,23,24,25,26. Photoexcitation of fluorescent proteins generates reactive oxygen species (ROS), which can cause photobleaching of the fluorescent proteins and damage to the biological samples27,28. Oxygen scavengers such as glucose, glucose oxidase and catalase are routinely used in motility assays to limit photodamage and prolong the bleaching time of fluorescent proteins.
    8. Finally, add 1 µL of the purified motor to the above motility mix and mix well before flowing into the motility chamber.
    9. Seal both the ends of the motility chamber with liquid paraffin wax and immediately image under TIRF illumination using 100X TIRF objective of 1.49 NA with 1.5x magnification.
    10. In order to focus the coverslip surface, first, focus on one of the inner edges of double-sided tape in the motility chamber under differential interference contrast (DIC) illumination.
      NOTE: The bright and uneven surface will be visible.
    11. Then, move the focus into the motility chamber. Using fine adjustment, focus the coverslip surface and look for the microtubules adsorbed on the coverslip surface.
    12. Once the microtubules are focused, switch to TIRF illumination with a 488 nm excitation laser and adjust the illumination depth by changing the excitation beam angle to get the best and uniform TIRF illumination (Figure 4B).
    13. Focus the individual mCitrine-tagged motors moving processively along the microtubule surface with 100 ms exposure and record the motion using an EM-CCD camera.
      NOTE: Although the motility assays were performed on unlabeled microtubules, the maximum intensity z-projection function can be used to reveal the outline of the microtubule track. Preferentially, events on long microtubule tracks were considered for tracking analysis.
    14. Manually track the position of the fluorescently tagged individual motors walking on long microtubule tracks frame-by-frame using a custom-written plugin in ImageJ (nih.gov) software as described previously29.
    15. Generate the histograms of velocity and run length for the motor population by plotting the number of events in each bin. Fit these histograms to a single Gaussian peak function to obtain average velocity and run length12 (Figure 4C-E).

4. In vitro microtubule gliding assay

NOTE: To understand the collective behavior of kinesin-3 motors, in vitro microtubule gliding assay was performed18,30,31. Where motors are immobilized onto the coverslip in an inverted position and upon adding microtubules into the chamber, microtubules land on motors and glide along as the motors try to walk on them (Figure 5A,B).

  1. Fluorescent microtubule polymerization: Polymerize the microtubules following the protocol described previously except for mixing rhodamine labeled tubulin (3 mg/mL) with unlabeled tubulin (10 mg/mL) in a ratio 1:10.
  2. After 30 min of polymerization, gently add 30 µL of pre-warmed microtubule stabilization buffer and incubate further for 5 min at 37 °C.
  3. Next, shear the microtubules by pipetting with the capillary-loading tip (~25-30 times).
  4. Prepare the motility flow chamber as described previously, flow 50 µL of Sf9-purified GFP nanobodies (2.5 µL of 100 nM diluted in 50 µL of P12 buffer) and incubate for 30 min at room temperature with the coverslip facing downward in a moist chamber.
    NOTE: The motors are C-terminally tagged with mCitrine. GFP nanobodies are used to immobilize the motors due to their low dissociation constant32.
  5. Block the coverslip surface by flowing 50 µL of block buffer into the flow chamber to prevent nonspecific protein adsorption and incubate further for 5 min.
  6. Prepare the motor mix by pipetting 50 µL of block buffer, 1 µL of 100mM ATP, and 5 µL of 100 nM Sf9-purified kinesin-3 motors. Mix gently before flowing into the chamber and incubate for 30 min at room temperature in a moist chamber.
  7. Wash the chamber twice with 50 µL of P12 casein.
  8. In a sterile microcentrifuge tube, prepare the gliding assay mixture in the following order, 45 µL of P12-casein with 10 µM taxol, 1 µL of 100 mM ATP, 0.5 µL of 8 mg/mL catalase, 0.5 µL of 20 mg/mL glucose oxidase, 0.5 µL of 2.25 M glucose and 1 µL of sheared fluorescent microtubules. Gently mix the content before flowing into the motility chamber and seal the ends of the chamber with liquid paraffin wax.
  9. Image microtubule gliding under TIRF illumination at 100 ms exposure and capture the images with attached EM-CCD camera.
    NOTE: The average microtubule gliding velocity was determined by manually tracking approximately 100 individual microtubules frame-by-frame using a custom-written plugin in ImageJ29. Determine the average microtubule gliding velocity by generating a histogram and fitting to a Gaussian function (Figure 5C,D).

Wyniki

To express and purify active and functional recombinant motor proteins at a large scale using the Sf9-baculovirus expression, the system needs generation of viral particles stably carrying a coding sequence to infect Sf9 cells. To achieve this, Sf9 cells were transfected with recombinant bacmid encoding KIF1A(1-393LZ)-3xmCit-FLAG. After 72 h, a significant population of cells showed expression of green fluorescent protein (mCitrine) with enlarged cells and nuclei (Figure 1 and

Dyskusje

The Sf9-baculovirus expression system is one of the most versatile and successful methods for high-throughput protein production19,36,37. The posttranslational modification ability of Sf9 cells is highly comparable to the mammalian system15. A considerable disadvantage of using this system is that it is slow and sensitive to contamination. One of the most critical steps is efficient infection and successf...

Ujawnienia

The authors have no competing financial interests to declare.

Podziękowania

V.S. and P.S. thank Prof. Kristen J. Verhey (University of Michigan, Ann Arbor, MI, USA) and Prof. Roop Mallik (Indian Institute of Technology Bombay (IITB), Mumbai, India) for their unconditional support throughout the study. P.S. thanks Dr. Sivapriya Kirubakaran for her support throughout the project. V.S. acknowledges funding through DBT (Grant No.: BT/PR15214/BRB/10/1449/2015 and BT/RLF/Re-entry/45/2015) and DST-SERB (Grant No.: ECR/2016/000913). P.K.N acknowledges ICMR for funding (Grant No. 5/13/13/2019/NCD-III). P.S. acknowledges funding from DST (Grant No.: SR/WOS-A/LS-73/2017). D.J.S acknowledges fellowship from IIT Gandhinagar.

Materiały

NameCompanyCatalog NumberComments
Sf9 culture and transfection materials
anti-FLAG M2 affinityBiolegend651502For protein purification
AprotininSigmaA6279For protein purification
CellfectinInvitrogen10362100For Sf9 transfection
DTTSigmaD5545For motility assays and protein purification
FLAG peptideSigmaF3290For protein purification
GlycerolSigmaG5516To freeze the protein
HEPESSigmaH3375For Sf9 lysis buffer
IGEPAL CA 630SigmaI8896For Sf9 lysis buffer
KClSigmaP9541For buffers preparation
LeupeptinSigmaL2884For protein purification
MgCl2SigmaM2670For buffers preparation
NaClSigmaS7653For preparing lysis buffer
PMSFSigmaP7626For protein purification
Sf9 cellsKind gift from Dr. Thomas Pucadyil (Indian Institute of Science Education and Research, Pune, India).For baculovirs expression and protein purification
Sf9 culture bottlesThermo Scientific4115-0125For suspension culture
Sf-900/SFM medium (1X)Thermo Scientific10902-096 -500mlFor culturing Sf9 cells
SucroseSigmaS1888Preparing lysing buffer for Sf9 cells
Unsupplemented Grace’s mediaThermo Scientific11595030 -500mlFor Sf9 transfection
Mirotubule Polymerization and Single molecule assay materails
ATPSigmaA2647For motility and gliding assay
BSASigmaA2153For blocking motility chamber
CatalaseSigmaC9322For motility and gliding assay
DMSOSigmaD5879For dissolving Rhodamine
EGTASigma3777For preparing buffers
GlucoseSigmaG7021For motility and gliding assay
Glucose oxidaseSigmaG2133For motility and gliding assay
GTPSigmaG8877For microtubule polymerization
KOHSigmaP1767Preparing PIPES buffer pH 6.9
PIPESSigmaP6757For preparing motility and gliding assay buffers
Microtubule gliding assay materials
26G  needleDispovanFor shearing microtubules
CaseinSigmaC3400For microtubule glidning assay
GFP nanobodiesGift from Dr. Sivaraj Sivaramakrishnan (University of Minnesota, USA)For attaching motors to the coverslip
RhodamineThermo Scientific46406For preparing labelling tubulin
Microscope and other instruments
0.5ml, 1.5 and 2-ml microcentrifuge tubesEppendorfFor Sf9 culture and purification
10ml  disposable sterile pipettesEppendorfFor Sf9 culture and purification
10ul, 200ul, 1ml micropipette tipsEppendorfFor Sf9 culture and purification
15ml concal tubesEppendorfFor Sf9 culture and purification
35mm cell culture dishCole Palmer15179-39For Sf9 culture
BalanceSartorious0.01g-300g
Benchtop orbial shaking incubatorREMIFor Sf9 suspenculture at 28oC
CameraEMCCD Andor iXon Ultra 897For TIRF imaging and acquesition
Double sided tapeScotchFor making motility chamber
Glass coverslipFisherfinest12-548-5Asize; 22X30
Glass slideBlue StarFor making motility chamber
Heating blockNeuationDissolving paraffin wax
Inverted microscopeNikon Eclipse Ti- UTo check protein expression
Lasers488nm (100mW)For TIRF imaging
Liquid nitrogenFor sample freezing and storage
Microcapillary loading tipEppendorfEP022491920For shearing microtubules
MicroscopeNikon Eclipse Ti2-E with DIC set upFor TIRF imaging
Mini spinGenetix, BiotechAsia Pvt.LtdFor quick spin
Objective100X TIRF objective with 1.49NA oil immersionFor TIRF imaging
Optima UltraCentrifuge XEBeckman CoulterFor protein purification
ParafilmEppendorf
pH-meterCorningCoring 430To adjust pH
Pipette-boyVWRFor Sf9 culture and purification
Sorvall Legend Micro 21Thermo ScientificFor protein purification
Sorvall ST8R centrifugeThermo ScientificProtein purification
ThermoMixerEppendorfFor microtubule polymerization
Ultracentrifuge rotorBeckman coulterSW60Ti rotor
Ultracentrifuge tubesBeckman5 mL, Open-Top Thinwall Ultra-Clear Tube, 13 x 51mm
Vortex mixerNeuationSample mixing
WaxSigmaV001228To seal motility chamber

Odniesienia

  1. Vale, R. D. The molecular motor toolbox for intracellular transport. Cell. 112, 467-480 (2003).
  2. Miki, H., Okada, Y., Hirokawa, N. Analysis of the kinesin superfamily: insights into structure and function. Trends in Cell Biology. 15 (9), 467-476 (2005).
  3. Hirokawa, N., Niwa, S., Tanaka, Y. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron. 68 (4), 610-638 (2010).
  4. Hirokawa, N., Takemura, R. Molecular motors and mechanisms of directional transport in neurons. Nature Reviews Neuroscience. 6 (3), 201-214 (2005).
  5. Patel, N. M., et al. KIF13A motors are regulated by Rab22A to function as weak dimers inside the cell. Scientific Advances. 7 (6), (2021).
  6. Franker, M. A., Hoogenraad, C. C. Microtubule-based transport - basic mechanisms, traffic rules and role in neurological pathogenesis. Journal of Cellular Science. 126, 2319-2329 (2013).
  7. Gunawardena, S., Anderson, E. N., White, J. Axonal transport and neurodegenerative disease: vesicle-motor complex formation and their regulation. Degernative Neurological and Neuromuscular Disease. 4, 29-47 (2014).
  8. Rath, O., Kozielski, F. Kinesins and cancer. Nature Reviews Cancer. 12 (8), 527-539 (2012).
  9. Wang, Z. Z., et al. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer. International Journal of Oncology. 53 (5), 1939-1952 (2018).
  10. Guo, S. K., Shi, X. X., Wang, P. Y., Xie, P. Run length distribution of dimerized kinesin-3 molecular motors: comparison with dimeric kinesin-1. Scientific Reports. 9 (1), 16973 (2019).
  11. Scarabelli, G., et al. Mapping the processivity determinants of the Kinesin-3 motor domain. Biophysical Journal. 109 (8), 1537-1540 (2015).
  12. Soppina, V., et al. Dimerization of mammalian kinesin-3 motors results in superprocessive motion. Proceedings of the National Academy of Sciences of the United States of America. 111 (15), 5562-5567 (2014).
  13. Soppina, V., Verhey, K. J. The family-specific K-loop influences the microtubule on-rate but not the superprocessivity of kinesin-3 motors. Molecular Biology Cell. 25 (14), 2161-2170 (2014).
  14. Soppina, V., et al. Kinesin-3 motors are fine-tuned at the molecular level to endow distinct mechanical outputs. BMC Biology. , (2022).
  15. Korten, T., Chaudhuri, S., Tavkin, E., Braun, M., Diez, S. Kinesin-1 Expressed in insect cells improves microtubule in vitro gliding performance, long-term stability and guiding efficiency in nanostructures. IEEE Transactions on Nanobioscience. 15 (1), 62-69 (2016).
  16. Schmidt, F. R. Recombinant expression systems in the pharmaceutical industry. Applied Microbiology and Biotechnology. 65 (4), 363-372 (2004).
  17. Kurland, C., Gallant, J. Errors of heterologous protein expression. Current Opinions in Biotechnology. 7 (5), 489-493 (1996).
  18. Tao, L., Scholey, J. M. Purification and assay of mitotic motors. Methods. 51 (2), 233-241 (2010).
  19. Kost, T. A., Condreay, J. P., Jarvis, D. L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nature Biotechnology. 23 (5), 567-575 (2005).
  20. Felberbaum, R. S. The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors. Biotechnology Journal. 10 (5), 702-714 (2015).
  21. Kumar, N., Pandey, D., Halder, A., Kumar, D., Gong, C. . Trends in Insect Molecular Biology and Biotechnology. , 163-191 (2018).
  22. Nagano, T. Development of fluorescent probes for bioimaging applications. Proceedings of the Japan Academy. Series B. Physical and Biological Sciences. 86 (8), 837-847 (2010).
  23. Hassan, M., Klaunberg, B. A. Biomedical applications of fluorescence imaging in vivo. Comparative Medicine. 54 (6), 635-644 (2004).
  24. Yang, Z., Samanta, S., Yan, W., Yu, B., Qu, J. Super-resolution microscopy for biological imaging. Advances in Experimental Medicine and Biology. 3233, 23-43 (2021).
  25. Ettinger, A., Wittmann, T. Fluorescence live cell imaging. Methods in Cell Biology. 123, 77-94 (2014).
  26. Waters, J. C. Live-cell fluorescence imaging. Methods in Cell Biology. 114, 125-150 (2013).
  27. Zheng, Q., Jockusch, S., Zhou, Z., Blanchard, S. C. The contribution of reactive oxygen species to the photobleaching of organic fluorophores. Photochemistry and Photobiology. 90 (2), 448-454 (2014).
  28. Wojtovich, A. P., Foster, T. H. Optogenetic control of ROS production. Redox Biology. 2, 368-376 (2014).
  29. Cai, D., Verhey, K. J., Meyhofer, E. Tracking single Kinesin molecules in the cytoplasm of mammalian cells. Biophysical Journal. 92 (12), 4137-4144 (2007).
  30. Bohm, K. J., Stracke, R., Baum, M., Zieren, M., Unger, E. Effect of temperature on kinesin-driven microtubule gliding and kinesin ATPase activity. FEBS Letters. 466, 59-62 (2000).
  31. Porter, M. E., et al. Characterization of the microtubule movement produced by sea urchin egg kinesin. The Journal of Biological Chemistry. 262 (6), 2794-2802 (1987).
  32. Muyldermans, S. Nanobodies: natural single-domain antibodies. Annual Review of Biochemistry. 82, 775-797 (2013).
  33. Verma, S., Kumar, N., Verma, V. Role of paclitaxel on critical nucleation concentration of tubulin and its effects thereof. Biochemical and Biophysical Research Communications. 478 (3), 1350-1354 (2016).
  34. Parness, J., Horwitz, S. B. Taxol binds to polymerized tubulin in vitro. Journal of Cell Biology. 91 (2), 479-487 (1981).
  35. Schiff, P. B., Fant, J., Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol. Nature. 277 (5698), 665-667 (1979).
  36. Kato, T., Kageshima, A., Suzuki, F., Park, E. Y. Expression and purification of human (pro)renin receptor in insect cells using baculovirus expression system. Protein Expression and Purification. 58 (2), 242-248 (2008).
  37. Liu, F., Wu, X., Li, L., Liu, Z., Wang, Z. Use of baculovirus expression system for generation of virus-like particles: successes and challenges. Protein Expression and Purification. 90 (2), 104-116 (2013).
  38. Terpe, K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Applied Microbiology and Biotechnology. 60 (5), 523-533 (2003).
  39. Huang, S. T., et al. Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol. International Journal of Oncology. 53 (3), 1105-1117 (2018).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Single Molecule AnalysisSf9 Baculovirus SystemKinesin 3 Family MotorsMolecular MotorsSingle Molecule MotilityMulti motor Gliding AssaysMotor ProteinsPurification ProtocolCellular TransfectionCytoskeletal ProteinsDionineMyosinFluorescence MicroscopeBiochemical PropertiesBiophysical Properties

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone